Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    ((AT13387 AND GIST) OR NCT01245218 OR NCT00878423)
Show Display Options
Download search resultsDownload the search results for:
((AT13387 AND GIST) OR NCT01245218 OR NCT00878423) (3 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
Condition: Gastrointestinal Stromal Tumor (GIST)
Intervention: Drug: AT13387 and Imatinib
2 Completed Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
Condition: Metastatic Solid Tumors
Intervention: Drug: AT13387
3 Completed AT13387 in Adults With Refractory Solid Tumors
Conditions: Solid Tumors;   Breast Cancer
Intervention: Drug: AT13387

Indicates status has not been verified in more than two years